Rule-based, three-mode portfolio: shift to TLT on high VOOG volatility; hedge with UVXY when VOOG looks overbought; otherwise hold an equal-weight mix of AI/tech/biotech stocks plus the solar ETF TAN.

- It uses VOOG as the signal source. First, it checks how volatile VOOG has been recently (10-day window). If VOOG volatility is above a high threshold, the strategy allocates wholly to TLT (long-dated U.S. Treasuries) to reduce risk. - If VOOG volatility is not that high, it then checks whether VOOG is extremely overbought using a 10-day Relative Strength Index (RSI) on VOOG. If RSI is above 79, it buys UVXY to hedge against a spike in market volatility. - If neither condition is true, the strategy shifts to an equal-weighted basket of individual stocks and a solar ETF: NVDA, MSFT, AAPL, KLAC, MNST, ULTA, AZO, FLNG, KNSL, STLD, SGML, LLY, MRNA, and TAN. These represent AI/tech/biotech exposure plus a solar-energy tilt. - The “Solar-Powered Thunderdome AI Drug Insurance” label is just a name for the group; the actual assets are listed under the final else branch. - Rebalancing: none, with a very narrow rebalance corridor, meaning the positions aren’t routinely rebalanced unless the regime changes (no automatic quarterly/monthly rebalancing).

Out-of-sample annualized return 26.3% vs S&P 21.1%; Calmar ~1.22 indicates strong risk-adjusted gains. Regime hedges (TLT/UVXY) protect in turbulence, while a diversified AI/tech/biotech + solar tilt targets durable alpha.